英国孤立性冠状动脉旁路移植术后五年再入院情况
本研究基于英国国家成人心脏手术审计数据和医院统计数据库,纳入2013年1月至2025年4月所有接受孤立性冠状动脉旁路移植术的患者,分析术后60个月内全因再入院情况。共纳入101,759例患者,12个月和60个月累积再入院率分别为42.0%和68.2%,心血管相关再入院占12个月再入院的15%。
要点
- 术后12个月和60个月累积再入院率分别为42.0%和68.2%。
- 12个月时心血管相关再入院占15%,以心律失常、心衰和急性冠脉综合征为主。
- 术后13-60个月主要再入院诊断包括心律失常24.7%、心绞痛22.2%、心衰19.4%。
核心结论
- 在5年随访中,心血管相关再入院约占所有再入院四分之一。
- 再入院率高,需进一步研究原因并优化资源使用。
研究设计与样本
- 基于英国国家成人心脏手术审计数据集和医院统计数据库的回顾性队列研究。
- 纳入2013年1月至2025年4月所有接受孤立性冠状动脉旁路移植术的患者,共101,759例,其中84%为男性,中位年龄66.9岁(四分位距59.7-73.6)。
主要发现
- 69,426例患者需要全因再入院。
- 12个月和60个月累积再入院率分别为42.0%和68.2%。
- 12个月和60个月紧急再次血运重建发生率分别为1.71%和4.20%。
临床怎么用
- CABG术后远期再入院率高,应加强出院后随访和心血管危险因素管理。
- 关注心律失常、心衰和心绞痛等心血管原因,以及非心源性胸痛、伤口感染和贫血等手术相关原因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Data on hospital readmission and secondary care utilization after coronary artery bypass grafting (CABG) beyond 30 days remain limited. We aim to address this gap by reporting cardiovascular and procedure-related readmission rates in the 60 months after primary isolated surgical revascularization in the United Kingdom. METHODS: All patients who underwent isolated CABG from January 2013 to April 2025 from the UK National Adult Cardiac Surgery Audit dataset were included. All cause readmissions to any NHS hospital during the first 60 months of follow-up were analysed from the Hospital Episode Statistics dataset. The relation to the time before, during, and after the COVID-19 pandemic was also investigated. Finally, the primary and secondary diagnoses, as well as any procedure(s) undertaken during readmission, were evaluated. RESULTS: A total of 101,759 patients were identified (84% male, median age 66.9 years [first and third quartile: 59.7, 73.6]). Of these 69,426 patients, required readmission for any cause. The cumulative incidence of readmission at 12 and 60 months was 42.0% and 68.2%, respectively. The overall readmission rate during the first lockdown to the third lockdown relaxation of the COVID-19 pandemic was 42.0% (ranged: 40.7%-45.0%). No significant differences in readmission rates were observed during the COVID-19 pandemic. At 12 months, cardiovascular-related readmissions accounted for 15% (n = 13 529) of all readmissions, with arrhythmia 25%, heart failure 19% and acute coronary syndrome 15.2%. The primary diagnoses between 13 and 60 months 24.7% (n = 17 162) were arrhythmia, 22.2%, angina pectoris, 19.4%, heart failure 17.1%. The overall incidence of urgent repeat revascularization during readmission at 12 and 60 months was 1.71% and 4.20%, respectively. The primary readmission diagnoses related to the surgical procedure (excluding cardiovascular-related) in the first 12 months was 25.5% (n = 23 047), with non-cardiac chest pain 30.1%, surgical wound disruption/infection 16.8% and anaemia 15.0%. Between 13 and 60 months, procedure-related primary diagnoses accounted for 26.1% (n = 18 143), of which non-cardiac chest pain 35.6%, anaemia 26.2%, and respiratory tract infection 20.8%. CONCLUSIONS: Analysis of this unselected UK cohort reveals that cardiovascular-related readmission represented one-quarter of all readmissions at 5 years after the index CABG. This high readmission rate underscores the need for further research to understand the underlying causes and implement strategies to optimize resource use.
引用
- Chan J, Comanici M, Dong T, et al. Five-Year Hospital Readmission After Isolated Coronary Artery Bypass Grafting in the United Kingdom. Eur J Cardiothorac Surg. 2026. PMID: 41886338. doi:10.1093/ejcts/ezag139
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。